Where does Genocea Biosciences, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Genocea Biosciences, Inc. ranks #18,659 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Genocea Biosciences, Inc. hold?

Genocea Biosciences, Inc. holds 15 US utility patents granted between 2015 and 2021, spanning 9 technology areas.

What is Genocea Biosciences, Inc.'s Innovation Score?

Genocea Biosciences, Inc. has an Innovation Score of 35.2 out of 100 (top 50% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Genocea Biosciences, Inc. focus on?

Genocea Biosciences, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 11 patents, ranking #2,031 of 7,163 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Genocea Biosciences, Inc.'s patent grant rate increasing or decreasing?

Genocea Biosciences, Inc.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Genocea Biosciences, Inc.'s patents?

Genocea Biosciences, Inc.'s patents average 30.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Genocea Biosciences, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Genocea Biosciences, Inc.

USPTO PatentsView assignee record - 15 granted patents across 9 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Genocea ranks #18,659 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 9 technology areas.

#18,659
of 49,997 US assignees by volume: Top 50%
by Innovation Score (35.2/100): 30.1
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18659 · US Corporation #18,659 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,659/49,997
PHOTO-FINISH Gateway Plastics
CPC-NARROW A61K · 9 areas
INNOV-THIN 35.2/100
CLAIMS-DENSE 30.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Gateway Plastics, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Genocea’s 35.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (27%) Velocity 0.0 pts (0%) Breadth 10.6 pts (30%) Claim depth 15.0 pts (43%)

Qualcomm Incorporated · highest

85
Genocea Biosciences · this assignee

35
3D Lighting… · lowest

7

What this shows Genocea's Innovation Score is 35.2/100 (top 50% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Genocea?

Each dot is one of Genocea’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Genocea’s own 30.1 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Genocea vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Genocea's grants concentrate

Genocea Biosciences, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 73.3% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2017 (3 grants) versus a trough of 1 in 2015. By volume, Genocea sits between Gateway Plastics, Inc. and GlobalFoundries Dresden Module One Limited Liability Company & Co. KG.

Gateway Plastics

15
Gelesis

15
Gen-y Creations

15
General Instrument

15
Genova

15
Genpak

15
Gigavac

15
Globalfoundries D…

15
Genocea Bioscienc… ◀

15

What this shows Genocea holds 15 patents at rank #18,676, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Genocea

By rank, the assignees closest to #18,676 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Genocea's primary technology class.

Genocea's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

35 Top 50% higher than 50% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Genocea Biosciences, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	6.7%
2016	1	6.7%
2017	3	20.0%
2018	3	20.0%
2019	2	13.3%
2020	3	20.0%
2021	2	13.3%

Which technologies does Genocea Biosciences, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 11

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 10

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 9

C07K - Peptides 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 5

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 1

Y02A - Technologies FOR Adaptation TO Climate Change 1

G16H - Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Genocea Biosciences, Inc.'s patent record in context - here's where to go next.

Genocea Biosciences, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 73.3% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #18,659 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Genocea Biosciences, Inc. against Gateway Plastics, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 35.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.